JP2025510311A5 - - Google Patents
Info
- Publication number
- JP2025510311A5 JP2025510311A5 JP2024557475A JP2024557475A JP2025510311A5 JP 2025510311 A5 JP2025510311 A5 JP 2025510311A5 JP 2024557475 A JP2024557475 A JP 2024557475A JP 2024557475 A JP2024557475 A JP 2024557475A JP 2025510311 A5 JP2025510311 A5 JP 2025510311A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- patient
- compound
- psoriasis
- compound represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263324754P | 2022-03-29 | 2022-03-29 | |
| US63/324,754 | 2022-03-29 | ||
| US202263344126P | 2022-05-20 | 2022-05-20 | |
| US63/344,126 | 2022-05-20 | ||
| US202263408572P | 2022-09-21 | 2022-09-21 | |
| US63/408,572 | 2022-09-21 | ||
| US202263429720P | 2022-12-02 | 2022-12-02 | |
| US63/429,720 | 2022-12-02 | ||
| PCT/US2023/016677 WO2023192351A1 (en) | 2022-03-29 | 2023-03-29 | Tyk2 inhibitors and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025510311A JP2025510311A (ja) | 2025-04-14 |
| JP2025510311A5 true JP2025510311A5 (enExample) | 2026-04-06 |
Family
ID=86142785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024557475A Pending JP2025510311A (ja) | 2022-03-29 | 2023-03-29 | Ｔｙｋ２阻害剤およびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250205211A1 (enExample) |
| EP (1) | EP4499092A1 (enExample) |
| JP (1) | JP2025510311A (enExample) |
| KR (1) | KR20240166011A (enExample) |
| CN (1) | CN119546299A (enExample) |
| AU (1) | AU2023245329A1 (enExample) |
| CA (1) | CA3246725A1 (enExample) |
| IL (1) | IL315866A (enExample) |
| MX (1) | MX2024011860A (enExample) |
| TW (1) | TW202342000A (enExample) |
| WO (1) | WO2023192351A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121909018A (zh) * | 2023-09-20 | 2026-04-21 | 阿鲁米斯公司 | Tyk2抑制剂的立即释放制剂 |
| WO2026136251A1 (en) * | 2024-12-16 | 2026-06-25 | Alumis Inc. | Tyk2 inhibitor for treating neuroinflammatory or neurodegenerative diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS66346B1 (sr) | 2018-10-22 | 2025-01-31 | Alumis Inc | Inhibitori tyk2 i njihova upotreba |
| US20230295119A1 (en) * | 2020-04-14 | 2023-09-21 | Gossamer Bio Services, Inc. | Substituted pyridines for the treatment of inflammatory diseases |
| WO2021237121A1 (en) * | 2020-05-21 | 2021-11-25 | Gossamer Bio Services, Inc. | Substituted pyridines |
-
2023
- 2023-03-29 TW TW112111997A patent/TW202342000A/zh unknown
- 2023-03-29 IL IL315866A patent/IL315866A/en unknown
- 2023-03-29 EP EP23719158.0A patent/EP4499092A1/en active Pending
- 2023-03-29 CN CN202380030453.6A patent/CN119546299A/zh active Pending
- 2023-03-29 CA CA3246725A patent/CA3246725A1/en active Pending
- 2023-03-29 KR KR1020247035511A patent/KR20240166011A/ko active Pending
- 2023-03-29 WO PCT/US2023/016677 patent/WO2023192351A1/en not_active Ceased
- 2023-03-29 JP JP2024557475A patent/JP2025510311A/ja active Pending
- 2023-03-29 US US18/852,039 patent/US20250205211A1/en active Pending
- 2023-03-29 AU AU2023245329A patent/AU2023245329A1/en active Pending
-
2024
- 2024-09-26 MX MX2024011860A patent/MX2024011860A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5973411B2 (ja) | 医薬組成物 | |
| US10940116B2 (en) | Delayed release deferiprone tablets and methods of using the same | |
| JP2009513713A5 (enExample) | ||
| JP2018516951A (ja) | 夜間胃酸過分泌に対するベンズイミダゾール誘導体の使用 | |
| TW202617156A (zh) | 用於治療進行性纖維化間質性肺病之新穎口服醫藥組合物及劑量療法 | |
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| CN102143687A (zh) | 4-氨基吡啶在改善具有脱髓鞘和其它神经系统状况的患者的神经-认知和/或神经-精神病学损伤中的用途 | |
| JP6134064B2 (ja) | ピペラジン化合物、及びドネペジルを含む認知障害関連疾病の予防用または治療用の薬学的組成物 | |
| EP2175850B1 (en) | Treatment of anxiety | |
| WO2024129619A9 (en) | Stat3 inhibitors for use in the treatment of non-viral liver cancer | |
| TWI783921B (zh) | 手部溼疹之治療 | |
| US20120122919A1 (en) | Pharmaceutical composition combining tenatoprazole and a histamine h2-receptor antagonist | |
| CN117412751A (zh) | 用于预防或治疗肺纤维化的药物制剂 | |
| WO2023066330A1 (zh) | 依达拉奉在自闭症谱系障碍治疗中的应用 | |
| JP6914626B2 (ja) | 経口用医薬組成物 | |
| JP2024532129A5 (enExample) | ||
| EP2184284B1 (en) | Preventive, inhibitor or remedy for cerebral aneurysm comprising ibudilast as an active ingredient | |
| JP2024543347A5 (enExample) | ||
| TW202220650A (zh) | 5-甲基-1,2,4-噁二唑-3-基化合物之低劑量療法及調配物 | |
| JP2023504205A5 (enExample) | ||
| JP2019001830A (ja) | 医薬 | |
| TW202408499A (zh) | 降低血中肌肉生長抑制素之藥劑 | |
| JP2009501205A (ja) | 精神病治療用組成物 | |
| JP2023543131A5 (enExample) | ||
| JP2021123530A (ja) | 多発性骨髄腫の治療剤 |